Table 2.
Clinical Outcomes Within 60 Days of Discharge in the Intervention Including 362 Intervention-Arm Patients and 126 Control-Arm Patients.a
| Intervention Arm |
Control Arm |
||||
|---|---|---|---|---|---|
| Characteristic | Total (N = 488) |
Pre-Intervention (N = 215) |
Post-Intervention (N = 147) |
Pre-Intervention (N = 70) |
Post-Intervention (N = 56) |
| Readmitted or ED visit, 60 days | 199, 40.8% | 82, 38.1% | 41, 27.9% | 35, 50.0% | 16, 28.6% |
| Readmitted, 60 days | 163, 33.4% | 75, 34.9% | 39, 26.5% | 33, 47.1% | 16, 28.6% |
| ED visit, 60 days | 117, 24.0% | 55, 25.6% | 27, 18.4% | 23, 32.9% | 12, 21.4% |
| Readmitted or ED visit, 30 days | 135, 27.7% | 65, 30.2% | 32, 21.8% | 26, 37.1% | 12, 21.4% |
| Readmitted, 30 days | 123, 25.2% | 58, 27.0% | 28, 19.1% | 25, 35.7% | 12, 21.4% |
| ED visit, 30 days | 92, 18.9% | 44, 20.5% | 23, 15.7% | 15, 21.4% | 10, 17.9% |
| Readmitted or ED visit, 7 days | 44, 9.02% | 23, 10.7% | 9, 6.12% | 8, 11.4% | 4, 7.14% |
| Readmitted, 7 days | 33, 6.76% | 20, 9.30% | 5, 3.40% | 6, 8.57% | 3, 5.36% |
| ED visit, 7 days | 34, 6.97% | 18, 8.37% | 8, 5.44% | 3, 4.29% | 4, 7.14% |
| Death | 37, 7.58% | 9, 4.19% | 8, 5.44% | 12, 17.1% | 8, 14.3% |
| Follow-up keptb | 248, 68.5% | 131, 60.9% | 117, 79.6% | — | — |
| Week 1 laboratory results seen by IDc | 210, 60.5% | 77, 37.4% | 133, 94.3% | — | — |
| Antimicrobial error at discharged | 41, 11.3% | 39, 18.1% | 2, 1.36% | — | — |
| Antimicrobial adverse event | 62, 17.1% | 36, 16.7% | 20, 13.6% | — | — |
| Catheter complication | 41, 11.3% | 25, 11.6% | 10, 6.80% | — | — |
| Relapse of infection | 48, 13.3% | 26, 12.1% | 11, 7.48% | — | — |
| Clostridium difficile infection | 3, 0.83% | 2, 1.59% | 1, 0.68% | — | — |
Abbreviations: ED, emergency department; ID, infectious diseases.
Days are days after discharge. Outcomes are at 60 days after discharge unless otherwise indicated. Readmission and ED outcomes, as well as death, were collected in the intervention and control groups. Other analyses are in the intervention group only. Chi-square and ANOVA tests, as appropriate, were used to demonstrate differences between groups (pre-intervention period intervention arm, post-intervention period intervention arm, pre-intervention period control arm, and post-intervention period control arm). ANOVA was used for continuous variables, whereas χ2 analyses were used for categorical variables.
Follow-up appointment kept with an ID provider within 60 days of discharge.
Laboratory test results seen by a member of the ID practice within the first week of discharge. Fifteen missing patients were readmitted or completed their OPAT courses within 1 week of discharge.
Difference in antimicrobial therapy agent between what was recommended by the inpatient ID team and what was written on the patient’s discharge summary.